Key result
Cardiopulmonary rehabilitation nursing significantly improved pulmonary function, sleep quality, and quality of life, while its absence was identified as an independent risk factor for adverse outcomes (OR 1.326) in COVID-19 patients.
Why the study?
The study was conducted to elucidate the impact of cardiopulmonary rehabilitation nursing on pulmonary function, sleep quality, and living ability in patients with COVID-19.
Does cardiopulmonary rehabilitation nursing improve pulmonary function, sleep quality, and living ability in hospitalized COVID-19 patients?
Cohort (n=98)
No
Does cardiopulmonary rehabilitation nursing improve pulmonary function, sleep quality, and living ability in hospitalized COVID-19 patients?
Odds Ratio: 1.326 (95% CI 0.951–1.985)
p-value: p=0.001
Cardiopulmonary rehabilitation nursing significantly improves pulmonary function, sleep quality, and quality of life while reducing inflammation in hospitalized COVID-19 patients.
May support rehab nursing benefits in COVID-19 recovery; hypothesis-generating and requires randomized confirmation before practice change.
OBJECTIVE: The purpose of this study was to elucidate the impact of cardiopulmonary rehabilitation nursing on the pulmonary function, sleep quality, and living ability of patients afflicted with Coronavirus Disease 2019 (COVID-19). METHODS: A total of 98 patients with COVID-19 treated at The People's Hospital of Guang'an between September 2021 and January 2023 were retrospectively collected as the research subjects. Among them, 48 patients who received standard nursing care from September 2021 to September 2022 were set as the control group, and 50 patients who underwent cardiopulmonary rehabilitation nursing from October 2022 to January 2023 were set as the research group. The pulmonary function indicators [including Forced Expiratory Volume in 1 second (FEV1) and Left Ventricular Ejection Fraction (LVEF)], sleep quality [evaluated using the Pittsburgh Sleep Quality Index (PSQI)], and living ability [assessed by the 36-Item Short Form Survey (SF-36) scale] pre- and post-intervention were compared between the two groups. RESULTS: <0.05). Multifactorial logistic regression analysis showed that non-receipt of cardiopulmonary rehabilitation, age ≥60 years, concurrent respiratory failure, coexistent heart failure, and acid-base imbalance were independent risk factors of adverse outcomes in COVID-19 patients (P<0.05). CONCLUSION: Application of cardiopulmonary rehabilitation nursing in COVID-19 patients can significantly improve pulmonary function, sleep quality, and overall quality of life, and relieve the inflammatory state of the patients, thereby enhancing prognosis. This approach has certain value of popularization and application.
No takes yet. Share an insight, caveat, or question.
Hua Chen (2024) conducted a cohort in COVID-19 (n=98). Cardiopulmonary rehabilitation nursing vs. Standard nursing care was evaluated on Adverse outcomes (poor prognosis) (OR 1.326, 95% CI 0.951-1.985, p=0.001). Cardiopulmonary rehabilitation nursing significantly improved pulmonary function, sleep quality, and quality of life, while its absence was identified as an independent risk factor for adverse outcomes (OR 1.326) in COVID-19 patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: